Dr. Allen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton Street Southeast
Minneapolis, MN 55455
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neuromuscular Medicine (Neurology), 2007 - 2008
Tufts Medical CenterResidency, Neurology, 2003 - 2006
Wayne State University School of MedicineClass of 2003
Certifications & Licensure
MN State Medical License 2014 - 2025
IL State Medical License 2008 - 2023
MA State Medical License 2007 - 2008- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Publications & Presentations
PubMed
- Inflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatmen...Milou R Michael, Luuk Wieske, Jeffrey A Allen, Michael P Lunn, Kathrin Doppler
BMC Neurology. 2024-10-25 - New chronic inflammatory demyelinating polyneuropathy/Guillain-Barré syndrome guidelines - impact on clinical practise.Jeffrey A Allen
Current Opinion in Neurology. 2024-10-01 - 2 citationsSafety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, ran...Jeffrey A Allen, Jie Lin, Ivana Basta, Tina Dysgaard, Christian Eggers
The Lancet. Neurology. 2024-10-01
Press Mentions
FDA Approves New Treatment for Chronic Inflammatory Demyelinating PolyneuropathyJune 25th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
